Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium

被引：0
|
作者：
Wong, JB [1 ]
Nevens, F [1 ]
机构：
[1] Tufts Univ, Sch Med, New England Med Ctr, Tupper Res Inst,Dept Med,Div Clin Decis Making, Boston, MA 02111 USA
来源：
ACTA GASTRO-ENTEROLOGICA BELGICA | 2002年 / 65卷 / 02期
关键词：
hepatitis C; cost-effectiveness analysis; interferon; ribavirin;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：110 / 111
页数：2
相关论文
共 50 条
  • [31] Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
    Davis, GL
    Wong, JB
    McHutchison, JG
    Manns, MP
    Harvey, J
    Albrecht, J
    [J]. HEPATOLOGY, 2003, 38 (03) : 645 - 652
  • [32] Costs of antiviral treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.
    Siebert, U
    Sroczynski, G
    Wasem, J
    Aidelsburger, P
    Rossol, S
    Wong, JB
    [J]. HEPATOLOGY, 2002, 36 (04) : 598A - 598A
  • [33] Estimating the cost-effectiveness of ribavirin and pegylated interferon alfa-2B for chronic hepatitis C.
    Wong, JB
    [J]. HEPATOLOGY, 2000, 32 (04) : 425A - 425A
  • [34] Peginterferon alfa-2b plus ribavirin for chronic hepatitis C virus infection genotype 4
    Shiha, Gamal
    Elshennaw, Hassan
    Abbas, Baha
    Khaled, Zalata
    Attia, Mohamed
    Farouk, Doaa
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A25 - A25
  • [35] Cost-effectiveness of interferon alfa-2b with and without ribavirin as therapy for chronic hepatitis C in Sweden
    Sennfält, K
    Reichard, O
    Hultkrantz, R
    Wong, JB
    Jonsson, D
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (08) : 870 - 876
  • [36] Responses to peginterferon alfa-2a vs alfa-2b plus ribavirin in a Mexican population with chronic hepatitis C
    Luis Sandoval-Ramirez, Jorge
    Antonio Mata-Marin, Jose
    Huerta-Garcia, Gloria
    Enrique Gaytan-Martinez, Jesus
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2015, 9 (03): : 267 - 273
  • [37] Impact of optimized treatment algorithms on the cost-effectiveness of ribavirin and peginterferon alfa-2B for chronic hepatitis C.
    Wong, JB
    McHutchison, JG
    Manns, MP
    Davis, GL
    Albrecht, JK
    [J]. HEPATOLOGY, 2002, 36 (04) : 717A - 717A
  • [38] Responses to peginterferon alfa-2a versus alfa-2b plus ribavirin in a Mexican population with chronic hepatitis C
    Sandoval, J.
    Mata, J.
    Gaytan, J.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2013, 20 : 25 - 25
  • [39] Cost-effectiveness of ribavirin interferon alfa-2B after interferon relapse in chronic hepatitis C.
    Wong, JB
    Davis, GL
    Pauker, SG
    [J]. HEPATOLOGY, 1998, 28 (04) : 591A - 591A
  • [40] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
    McHutchison, John G.
    Lawitz, Eric J.
    Shiffman, Mitchell L.
    Muir, Andrew J.
    Galler, Greg W.
    McCone, Jonathan
    Nyberg, Lisa M.
    Lee, William M.
    Ghalib, Reem H.
    Schiff, Eugene R.
    Galati, Joseph S.
    Bacon, Bruce R.
    Davis, Mitchell N.
    Mukhopadhyay, Pabak
    Koury, Kenneth
    Noviello, Stephanie
    Pedicone, Lisa D.
    Brass, Clifford A.
    Albrecht, Janice K.
    Sulkowski, Mark S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (06): : 580 - 593
12345